|
NKIRAS1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62436730732907E-12 |
| Normal-vs-Stage2 |
6.38660000440439E-08 |
| Normal-vs-Stage3 |
5.72920000330157E-08 |
| Normal-vs-Stage4 |
2.48720000000091E-05 |
| Stage1-vs-Stage2 |
5.703400E-01 |
| Stage1-vs-Stage3 |
5.170600E-01 |
| Stage1-vs-Stage4 |
3.754800E-01 |
| Stage2-vs-Stage3 |
9.910200E-01 |
| Stage2-vs-Stage4 |
6.220600E-01 |
| Stage3-vs-Stage4 |
6.803800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
5.00179897500175E-11 |
| Normal-vs-Asian |
1.635590E-01 |
| Caucasian-vs-AfricanAmerican |
4.352600E-01 |
| Caucasian-vs-Asian |
7.868400E-01 |
| AfricanAmerican-vs-Asian |
8.739000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
1.51679999671472E-08 |
| Male-vs-Female |
2.202400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.02171612784241E-13 |
| Normal-vs-Extreme_Weight |
<1E-12 |
| Normal-vs-Obese |
6.95887791835048E-13 |
| Normal-vs-Extreme_Obese |
8.308200E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.867800E-01 |
| Normal_Weight-vs-Obese |
4.293000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.488600E-01 |
| Extreme_Weight-vs-Obese |
3.419200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.405000E-01 |
| Obese-vs-Extreme_Obese |
3.789800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.249400E-04 |
| Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(81-100Yrs) |
6.202000E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.385600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.439400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.462400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.862200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.367000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.414400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
1.62558855265615E-12 |
| Normal-VS-KIRP CIMP |
3.242100E-02 |
| Normal-VS-Unclassified PRCC |
1.1188000526019E-09 |
| Type1 PRCC-VS-Type2 PRCC |
3.449800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.103800E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.135000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.762300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
8.421800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.375900E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.44804176929847E-13 |
| Normal-vs-N1 |
1.50169987556126E-10 |
| Normal-vs-N2 |
3.171500E-02 |
| N0-vs-N1 |
9.277200E-01 |
| N0-vs-N2 |
3.096600E-01 |
| N1-vs-N2 |
1.812970E-01 |
|
|
